Connect
← Return to ARPI use after radiation treatment may be an issue
Discussion
ARPI use after radiation treatment may be an issue
Prostate Cancer | Last Active: May 17 11:19am | Replies (46)Comment receiving replies
@surftohealth88
The only problem is that Nubeqa Is approved for metastatic, castrate sensitive Prostate cancer. If you are castrate sensitive, but don’t have metastasis than some doctors will not give you a prescription for it.
It looks like a lot more Doctors are opening up to the fact that it’s a better drug, and will prescribe it anyway.
Replies to "@surftohealth88 The only problem is that Nubeqa Is approved for metastatic, castrate sensitive Prostate cancer. If..."
Connect
@jeffmarc Getting a proscription may be one problems but getting reimbursed from your insurance could be another problem if your insurance plan follows FDA approvals.